Top Story

Aldeyra submits IND application for phase 2 testing of uveitis treatment

December 19, 2014

Aldeyra Therapeutics has submitted an investigational new drug application to the U.S. Food and Drug Administration to conduct phase 2 clinical testing of its product, NS2, for the treatment of noninfectious anterior uveitis.

“The submission of an IND for NS2 in the treatment of noninfectious anterior uveitis is a major milestone for Aldeyra and is another step forward in the execution of our development strategy,” Todd C. Brady, MD, PhD, president and CEO of Aldeyra, said in a company press release. “NS2 has the potential to reduce or eliminate the use of steroids in the treatment of this disease, which we believe would significantly enhance the treatment options for these patients and improve their long-term ocular health.”

thumbnail for video 3948373717001 Meeting News CoverageVideo

VIDEO: Vitreoretinal surgery update for the anterior segment surgeon

December 19, 2014
NEW YORK — John W. Kitchens, MD, discusses misconceptions people have about retina surgery at OSN New York.
In the Journals

Conventional, accelerated cross-linking yield similar outcomes

December 18, 2014
Conventional and accelerated corneal cross-linking had comparable anatomic and visual outcomes in treating keratoconus, according to study findings.The prospective…
Blog

Assessing, improving your physician management style, part 3

December 18, 2014
Finally, I’d like you to score yourself on the following quiz, filling in the blank lines with one of the following four words:“Always” — 3 points
“Sometimes” — 2…
thumbnail for video 3948296533001 Meeting News CoverageVideo

VIDEO: Macular therapeutics update

December 18, 2014
NEW YORK — Andrew Moshfeghi, MD, MBA, discusses recent advances in retina technology, as well as future developments, in his presentation from OSN New York.
More News Headlines »
Short Subjects

Presumed Ocular Juvenile Xanthogranuloma and Biopsy-Proven Cutaneous Mastocytosis Occurring Sequentially in a Young Boy

Journal of Pediatric Ophthalmology and Strabismus, Volume -2147483648
Online Only, December 12, 2014
Juvenile xanthogranuloma is a benign non-Langerhans cell histiocytosis characterized by skin lesions that tend to be…
More »
CME
Haller

Diabetic Eye Disease: Implications of Early Recognition, Treatment, and Continuity of Care

This activity is supported by an educational grant from Genentech, Inc.

Diabetic retinopathy is a leading cause of new cases of legal blindness among working-age Americans. Initially…
More »
Meeting News Coverage Video
thumbnail for video 3932502583001

VIDEO: Controversies in pterygium surgery

December 17, 2014
NEW YORK — At OSN New York, William B. Trattler, MD, dispels misconceptions about pterygium surgery.
More »
morganatic-roan